Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03208049 · ClinicalTrials.gov registry record · NA

Predictors of Response to Insomnia Treatments for Gulf War Veterans

A NA study of Insomnia, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
50
Enrollment target
3
Study locations

NCT03208049 is a NA study of Insomnia that has completed, run by VA Office of Research and Development. The registered enrollment target is 50 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03208049, a NA study of Insomnia, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to evaluate the efficacy and effectiveness of Behavioral Therapy (BT) and Cognitive Therapy (CT) in Gulf War Veterans with insomnia. The Primary Outcome measure is the Insomnia Severity Index (ISI).

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Therapy (BT)
  • BEHAVIORAL Cognitive Therapy (CT)

Study Locations (3)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

District of Columbia

  • Washington DC VA Medical Center, Washington, DC - Washington D.C.

New Jersey

  • East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ - East Orange

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-08-01
Est. Completion 2023-05-21
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03208049

The ClinicalTrials.gov registry entry for NCT03208049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (71% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Therapy (BT) is the first listed.

NCT03208049 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, District of Columbia, New Jersey.

Frequently Asked Questions

What is clinical trial NCT03208049 about?

NCT03208049 is a clinical study titled "Predictors of Response to Insomnia Treatments for Gulf War Veterans". The purpose of this study is to evaluate the efficacy and effectiveness of Behavioral Therapy (BT) and Cognitive Therapy (CT) in Gulf War Veterans with insomnia. The Primary Outcome measure is the Insomnia Severity Index (ISI).

What is the current status of trial NCT03208049?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-08-01. Estimated completion is 2023-05-21.

What conditions does trial NCT03208049 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT03208049?

The interventions under investigation include: Behavioral Therapy (BT) (BEHAVIORAL), Cognitive Therapy (CT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03208049?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03208049 being conducted?

This trial has 3 study locations across California, District of Columbia, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.